Simron Singh, MD (Medical Oncology)
Sunnybrook Health Science Centre
2075 Bayview Avenue, Room T2-047
Dr. Singh’s research interests include neuroendocrine carcinomas as well as population health and cancer care utilization discrepancies. Currently Dr. Singh is co-director of a newly established multidisciplinary specialized neuroendocrine clinic at the Sunnybrook Odette Cancer Center in Toronto, one of the first of its kind in the region. He is involved in numerous activities in the area of neuroendocrine cancer including the role of Ki-67 as a prognostic marker and the utilization of healthcare resources in the diagnosis and treatment of NET patients. Dr. Singh is the provincial lead of person- centered care and the patient experience at Cancer Care Ontario. He is interested in understanding the NET patient journey from both a patient as well as payer and healthcare provider perspective. He is currently running educational programs for NETs patients as well as for healthcare providers.